SerenoCem™ granules in mastoid obliteration surgery: A 2‐year follow‐up case series of 55 patients to determine the risk of progressive bone resorption

Volume: 44, Issue: 6, Pages: 1153 - 1155
Published: Sep 11, 2019
Abstract
Clinical OtolaryngologyVolume 44, Issue 6 p. 1153-1155 CORRESPONDENCE: OUR EXPERIENCE SerenoCem™ granules in mastoid obliteration surgery: A 2-year follow-up case series of 55 patients to determine the risk of progressive bone resorption Matthew Cherko, Corresponding Author Matthew Cherko matthew.cherko1@nhs.net orcid.org/0000-0002-6230-0848 Department of Otorhinolaryngology, Wexham Park Hospital, Slough, UK Correspondence Matthew Cherko,...
Paper Details
Title
SerenoCem™ granules in mastoid obliteration surgery: A 2‐year follow‐up case series of 55 patients to determine the risk of progressive bone resorption
Published Date
Sep 11, 2019
Volume
44
Issue
6
Pages
1153 - 1155
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.